Stigma and Quality of life in Parkinson’s disease patients on different treatment regimens
Objective: To assess self reported quality of life (QOL) in patients with Parkinson’s disease (PD) under different treatment options and to evaluate the emotional burden…A Protocol to Test the Effects of TDCS on Consolidation of Writing Practice in Parkinson’s Disease
Objective: To investigate effects of transcranial direct current stimulation (tDCS) concurrently applied with writing practice on consolidation of motor learning in Parkinson’s disease (PD) when…Factors that interfere in the functionality according to Functional Independence Measure in people with Parkinson’s Disease.
Objective: Provide new evidence on the motor and non-motor factors that interfere with the decline in functionality, comparing objective and subjective instruments with Functional Independence…Impact of subthalamic deep brain stimulation on sensorimotor and motor cortical oscillatory activity in free-moving hemiparkinsonian rats
Objective: The effect of STN DBS on the spectral power of oscillatory activity in the classic frequency bands in the motor cortex (MCtx) and sensorimotor…Investigation into the causes of reduced caffeine levels in Parkinson’s disease
Objective: To find out whether PD patients show decreased salivary caffeine levels; to investigate CYP1A2-phenotype and caffeine absorption as possible causes of decreased caffeine levels…Certification of cause of death in patients with Parkinson’s Disease (PD)
Objective: To evaluate the accuracy of death certification in patients with PD. Background: The National Statistics Office guidance (1) suggests that doctors completing Medical Certificate…CSF levels of NFL (neurofilament light chain) in Parkinsons’ disease patients
Objective: The aim of this study was to assess cerebro-spinal fluid (csf) NFL levels in PD patients and healthy controls subjects. Background: Neurofilament light chain…Does information from the Personal KinetiGraph™ (PKG) influence neurologists´ treatment decisions?
Objective: To evaluate if PKG data influences neurologists´ treatment decisions in routine clinical care of patients with Parkinson´s disease. Background: The PKG movement recording system is…Application of the Movement Disorders Society Criteria for diagnosis of Progressive Supranuclear Palsy
Objective: Analyze the sensitivity, specificity of the Movement Disorders Society (MDS) criteria for progressive supranuclear palsy (PSP) and apply the multiple allocation extinction (MAX) rules…Limitations of Curcumin as a Therapeutic Agent in Rotenone Induced Dopaminergic Neurodegeneration: Insights from Drosophila Model of Parkinson’s Disease
Objective: To understand the efficacy of curcumin in rotenone induced Drosophila model of Parkinson’s disease. Background: Parkinson’s disease (PD) is the second most common neurodegenerative…
- « Previous Page
- 1
- …
- 111
- 112
- 113
- 114
- 115
- …
- 217
- Next Page »
